State Board Intelligence for 503A & 503B Pharmacies
503 Intel tracks all 50 state boards of pharmacy, DC, FDA, DEA and the courts. Each item tells you what happened, why it matters to a compounder, and where to read the source.
Free accounts see every headline. Summaries, sources and the meeting calendar are $99 per month.
Written for owners, pharmacists in charge and compliance leads at 503A pharmacies and 503B outsourcing facilities.
Votes, final and proposed rules, emergency rules, guidance and discipline against compounders, checked every weekday.
Every item ends with one plain line on what a compounder should do or watch, so you can act without reading the whole docket.
Each entry links to the board notice, register filing, FDA letter or court opinion it came from.
Pick the states you ship into and filter the feed to them. Federal actions always show.
Upcoming board meetings, rule hearings and comment deadlines with agendas as boards post them.
GLP-1s, peptides and Category 2 bulks, nonresident licensing, USP 797/800, office use, telehealth, prescriber authority and 503B rules.
Start free. Upgrade when you want the full picture. Cancel anytime from your billing page.
All 50 state boards of pharmacy plus DC, and the federal actions that drive them: FDA compounding guidance and warning letters, the 503A bulks list and Category 2 changes, DEA telemedicine rules, NABP programs and court rulings.
Items are gathered each weekday with AI-assisted research across board sites, state registers, FDA and the courts. Every item links to its source so you can confirm the details yourself.
No. 503 Intel summarizes public actions. Confirm details with the source and your counsel before acting.
Each subscription is one sign-in. Email us for team pricing.
Open the feed, choose Manage billing, and cancel. You keep access through the end of the period you paid for.
We'll email you a one-time sign-in link. No password to remember.